UROFOLLITROPIN for Assisted reproductive technology: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 7 adverse event reports in the FDA FAERS database where UROFOLLITROPIN was used for Assisted reproductive technology.
Most Reported Side Effects for UROFOLLITROPIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Ovarian hyperstimulation syndrome | 73 | 72.3% | 1 | 66 |
| Abdominal distension | 25 | 24.8% | 0 | 21 |
| Abdominal pain | 20 | 19.8% | 0 | 16 |
| Ascites | 13 | 12.9% | 0 | 13 |
| Nausea | 12 | 11.9% | 0 | 11 |
| Chest discomfort | 10 | 9.9% | 0 | 8 |
| Dyspnoea | 10 | 9.9% | 0 | 10 |
| Vomiting | 10 | 9.9% | 0 | 8 |
| Oliguria | 7 | 6.9% | 0 | 7 |
| Off label use | 5 | 5.0% | 0 | 4 |
| Pelvic fluid collection | 5 | 5.0% | 0 | 5 |
Other Indications for UROFOLLITROPIN
Ovulation induction (37)
In vitro fertilisation (26)
Product used for unknown indication (7)
Infertility (6)
Other Drugs Used for Assisted reproductive technology
GANIRELIX (388)
CHORIOGONADOTROPIN ALFA (345)
PROGESTERONE (263)
FOLLITROPIN (232)
TRIPTORELIN (175)
FOLLITROPIN\LUTROPIN ALFA (123)
GONADOTROPHIN, CHORIONIC (116)
FOLLITROPIN ALFA (104)
MENOTROPINS (86)
ESTRADIOL (85)